Bendamustine is a new chemotherapy drug that has expanded the ability to fight this disease.
苯达莫司汀是一种新的化疗药物，可以增强我们对抗这种疾病的能力。
In the study that led to the FDA approval, most patients were refectory to bendamustine and rituximab.
在向FDA申报批准的临床研究中，大部分病人都对苯达莫司汀和利妥昔单抗耐药。
As a new generation of anti-cancer drugs, bendamustine has an obvious effect on a wide range of cancers.
盐酸苯达莫司汀作为新一代抗癌药物，对多种癌症具有明显的治疗作用。
应用推荐